英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字,中文词皆可:


请选择你想看的字典辞典:
单词字典翻译
tempus查看 tempus 在百度字典中的解释百度英翻中〔查看〕
tempus查看 tempus 在Google字典中的解释Google英翻中〔查看〕
tempus查看 tempus 在Yahoo字典中的解释Yahoo英翻中〔查看〕





安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Tempus | AI-enabled precision medicine
    Tempus has built the world’s largest library of clinical molecular data and an operating system to make that data accessible and useful, starting with cancer
  • Tempus AI - Wikipedia
    Tempus uses data and artificial intelligence (AI) to create precision medicine services, including diagnostics, [5] for oncology, cardiology, radiology, and depression The company went public on the Nasdaq on June 14, 2024, under the ticker symbol "TEM " [6][7]
  • How Investors Are Reacting To Tempus AI (TEM) Earnings Surge and New . . .
    Tempus AI recently reported third quarter 2025 earnings, highlighted by revenue of US$334 21 million, up from US$180 93 million a year ago, and an improved net loss, while also announcing a new
  • Tempus AI Q3 Highlights: Cathie Wood-, Nancy Pelosi-Owned AI Stock . . .
    Tempus AI reports Q3 revenue of $334 21M, up 84 7% YoY It also beat EPS estimates and raises full-year revenue guidance to $1 265B
  • Tempus - compcancercare. com
    TEMPUS® is a technology company that has built the world's largest library of clinical and molecular data and an operating system to make that information accessible and useful for patients, physicians and researchers
  • Tempus | SoftBank Group Corp.
    Launched in the United States in 2015, Tempus is now one of the largest sequencers of cancer patients in the world Having built its platform for oncology, it has expanded to neuropsychiatry, cardiology, infectious disease, and radiology
  • What Does Tempus AI Actually Do? Unveiling the AI Revolution in . . .
    In 2015, with a vision to revolutionize how doctors use data in clinical settings, Lefkofsky established Tempus The initial aim was to create a system where doctors could access a comprehensive, real-time view of a patient's medical history, including genomic, clinical, and imaging data
  • Tempus - 2025 Company Profile Team - Tracxn
    Tempus is a public company based in Chicago (United States), founded in 2015 by Eric Lefkofsky It operates as an AI-based precision medicine solutions for oncology
  • Providers - Tempus
    For clinicians associated with advanced research initiatives, Tempus provides next-generation genomic profiling, biological organoid modeling, image pattern AI recognition, and a range of clinical trial and research collaborations
  • Oncology Patients - Tempus
    Tempus is committed to providing access for patients without insurance and for those that choose to pay for services directly We encourage U S based patients to apply for financial assistance to see if you are eligible





中文字典-英文字典  2005-2009